MAPT and Alzheimer disease: For example, in Alzheimer’s disease (AD) research, MSD has been used to measure the levels of amyloid-beta (Aβ) and tau proteins in cerebrospinal fluid (CSF), both of which are key biomarkers for the diagnosis and progression of AD [16,17].